gastroesophageal reflux. Gastro-esophageal reflux disease
Conditions
Interventions
Intervention 1: Control group: Placebo, this capsule is prepared in Tuba Green Gold Pharmaceutical Company and medicinal corn starch is used as a placebo, which is filled in capsules of the same color
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: With reflux at the age of 18 to 80 years
Exclusion criteria
Exclusion criteria: Having a history of Barrett's esophagus History of esophageal or gastric surgery History of esophageal, gastric or abdominal cancer Having coagulation problems that prevent them from stopping their medication Patients receiving regular glucocorticoids and nonsteroidal anti-inflammatory drugs more than three days a week for the past 28 days Receiving sucralfate three days before enrollment Take aspirin daily at a dose of more than 150 mg Acute peptic ulcer or its complications Receive antibiotic treatment to eradicate Helicobacter Pylori in the last 28 days Smoking or Alcohol
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Heartburn. Timepoint: On arrival, the second week and fourth week. Method of measurement: Questionnaire.;Reflux throat. Timepoint: On arrival, the second week and fourth week. Method of measurement: Questionnaire.;Pain in the middle and upper stomach. Timepoint: On arrival, the second week and fourth week. Method of measurement: Questionnaire.;Nausea. Timepoint: On arrival, the second week and fourth week. Method of measurement: Questionnaire.;Difficulty in falling asleep due to reflux symptoms. Timepoint: On arrival, the second week and fourth week. Method of measurement: Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactRasool Choopani
Shahid Beheshti University of Medical Sciences
Outcome results
None listed